Star Pharmaceutical Ltd. | Income Statement
Fiscal year is January-December. All values SGD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
17,986.60
20,062.70
19,735.10
12,817.80
19,062.40
49,410.70
Cost of Goods Sold (COGS) incl. D&A
11,935.40
12,860.50
13,610.80
8,619.60
8,823.30
13,141.10
Gross Income
6,051.20
7,202.20
6,124.30
4,198.10
10,239.10
36,269.60
SG&A Expense
5,221.90
5,095.80
4,904.70
4,150.70
10,785.50
34,742.90
EBIT
574.60
-
1,090.80
84.40
3,425.30
1,465.10
Unusual Expense
-
459.00
609.20
-
1,363.90
434.50
Non Operating Income/Expense
521.30
7,158.20
790.60
653.60
87.40
949.20
Interest Expense
180.70
30.40
7.70
344.10
4.30
5.50
Pretax Income
959.50
9,756.20
1,821.20
787.60
4,750.40
2,183.10
Income Tax
360.10
500.30
503.00
249.00
492.50
207
Consolidated Net Income
599.40
10,256.50
1,318.10
538.70
4,257.90
2,390.10
Net Income
753.90
10,256.50
1,318.10
538.70
4,257.90
2,390.10
Net Income After Extraordinaries
753.90
10,256.50
1,318.10
538.70
4,257.90
2,390.10
Net Income Available to Common
753.90
10,256.50
1,318.10
538.70
4,257.90
2,390.10
EPS (Basic)
0.02
1.10
0.03
0.01
0.09
0.05
Basic Shares Outstanding
46,825.00
9,365.00
46,825.00
46,782.00
46,570.00
46,431
EPS (Diluted)
0.02
1.10
0.03
0.01
0.09
0.05
Diluted Shares Outstanding
46,825.00
9,365.00
46,825.00
46,782.00
46,570.00
46,431
EBITDA
3,002.70
3,803.20
2,433.90
1,132.20
2,188.70
2,943.70
Other Operating Expense
254.60
127.10
128.90
131.80
2,878.90
61.60
Non-Operating Interest Income
44.40
190.20
556.70
365.10
130.50
208.80
Minority Interest Expense
154.50
-
-
-
-
-
About Star Pharmaceutical
View Profile
